Drug resistance in mycobacterium tuberculosis: A four years experience

Journal of the Pakistan Medical Association

Volumn 49, Issue 11, 1999, Pages 262-265

  Karamat, K A ^a   Rafi, Shahid ^a   Abbasi, Shahid Ahmad ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; DRUG SCREENING; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE;

EID: 0033389983     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Sudre, Tendam PG, Kochi A. Tuberculosis: a global over view of the situation today. World Health, 1992;70:149-59.
2. Brown RA. Disease that is alive and kicking. World Health, 1993;71:4-5.
3. Wilson SM, McNereny R, Nye PM, et al. Progress towards a simplified polymerase chain reaction and its application to diagnosis of tuberculosis. Microbiol., 1993;31:776-81.
4. Aziz A, Siddiq SH, Aziz K, et al. Drug resistance of Mycobacterium tuberculosis isolated from treated patients in Pakistan. Tubercle, 1989;70:45-51.
5. Laidlaw M. Mycobacterium tubercle bacilli Mackie and McCartney, Practical medical microbiology 13th edn, Churchill Living Stone, Edinburgh, 1989, pp. 329-40.
6. Zhang LX. Treatment of multi-drug resistance in China. Chemotherapy, 1996,42:3:16-19.
7. Baker DA. Re-emergence of tuberculosis (editorial). Curr. Opin. Obstet. Gynae., 1994;6:373-76.
8. Moore M, Onorato IM, McCray E et al. Trends in drug resistant tuberculosis in the United States. JAMA, 1997;278:865-67.
9. Steiner P, Rao M, Mitchel M, et al. Primary drug resistant tuberculosis in children - emergence of primary drug resistant strains of M. tuberculosis to Rifampicin. Am. Rev. Respir. Dis., 1986;134:446-48.
10. Anonymous. Drug resistant tuberculosis (editorial). Br. Med. J., 1981;283:336-37.
11. Trevida SS, Desai SG. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujrat, India. Tubercle, 1988;69:37-42.
12. Schaaf HS, Botha P, Beyers N, et al. The five year outcome of MDR patients in the Cape Province of South Africa. Trop. Med. Int. Health, Oct. 1996;1:718-22.
13. Pablos-Mendez A, Raviglione MC, Laszlo A, et al. Global surveillance for anti-tuberculosis drug resistance, 1994-97. N. Engl. J. Med., 1998;338:1641-49.
14. Mahmood Z. Problem of secondary drug resistance in pulmonary tuberculosis. Proceedings from XV Eastern region conference of international union against tuberculosis and lung disease Lahore, Pakistan. Punjab Tuberculosis Association, Dec., 10-13; 1987, pp. 150-52.
15. Karamat KA, Butt T, Hannan A, et al. Susceptibility pattern of mycobacterial isolates at Rawalpindi/Islamabad. Pak. J. Pathol., 1995;6:39-42.
16. Serky JM. Multi-drug resistant tuberculosis: a new era in prevention and control. Dimens. Crit. Care. Nurs., 1995;14:236-44.
17. Nunn P, Kochi A. A deadly duo TB and AIDS. World Health, 1993;4:7-9.